30-Second Takeaway
- Hybrid telecare for type 2 diabetes can replace some visits while maintaining HbA1c and improving blood pressure and adherence.
- High-frequency home BP readings plus dedicated RPM nurses meaningfully boost short-term hypertension control.
- Non-specialist–delivered tiered iCBT reduces perinatal depression and is highly cost-effective in primary care.
- Potentially inappropriate prescribing in older adults strongly predicts ED visits, hospitalization, and mortality with clear dose–response.
- Activity, adherence support, and equity-focused workflows remain central amid high multimorbidity and behavioral risk burdens.
Week ending March 28, 2026
Practical levers for metabolic, cardiovascular, and mental health in family medicine
Hybrid telecare for type 2 diabetes matches usual care for HbA1c and improves blood pressure
In this single-blind non-inferiority RCT of 786 adults with type 2 diabetes, hybrid telecare maintained HbA1c comparable to in-person care over 84 weeks. The hybrid group alternated telecare and in-person visits and had consistently lower blood pressure than the in-person group. Medication adherence remained stable in the hybrid group but declined mid-trial in usual care, suggesting better treatment persistence. All seven clinics continued the telecare model post-trial, indicating real-world feasibility and comparable costs within a public system.
Frequent home BP readings plus dedicated nurses improve short-term hypertension control in RPM
Among 1464 RPM participants with hypertension, adequate home BP readings were associated with 10%–15% higher control at 4–12 weeks. Monitoring by dedicated Brook nurses, versus clinic staff, yielded up to 16% higher prevalence of BP control early in the program. Combining adequate readings with Brook nurse monitoring improved control by 17%–27% versus inadequate readings without Brook monitoring. Benefits emerged within four weeks, supporting intensive early engagement and dedicated staffing in primary care RPM programs.
Tiered non-specialist iCBT reduces perinatal depression and is highly cost-effective
This pragmatic primary care trial enrolled 428 pregnant women with EPDS ≥9, comparing tiered iCBT plus usual care with usual care alone. The iCBT group had greater EPDS reductions to six months postpartum and lower postpartum depression risk (aOR 0.46, 95% CI 0.27–0.79). Response rates improved (aOR 1.70, 95% CI 1.05–2.76), with similar favorable trends for anxiety and life satisfaction. Benefits were larger in moderate to severe depression, with minimal effect in mild cases, supporting symptom-stratified intensity. The program was highly cost-effective, with very low incremental cost per 1% increase in response, and used trained non-specialist providers.
Potentially inappropriate prescribing strongly linked to adverse outcomes in nearly 3 million older adults
This retrospective cohort followed 2,937,927 Ontario residents aged ≥65 years with at least one prescription over 14 years. STOPP-START–defined potentially inappropriate prescriptions were associated with higher odds of mortality (aOR 3.68) and hospitalization (aOR 4.86). Beers-defined inappropriate prescriptions similarly increased odds of mortality, hospitalization, ED visits, and a composite adverse outcome. Risk rose with each additional inappropriate prescription, with five or more STOPP-START triggers linked to nearly 15-fold higher mortality odds. Findings support routine use of STOPP-START and Beers criteria to prioritize medication review and deprescribing in primary care.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.